Laure Peyro-Saint-Paul

7PUBLICATIONS
7CO-AUTHORS
Litigation, adjudication and dispute resolutionMolecular targetsPharmacogenomicsBusiness ethicsPharmacology and pharmaceutical sciences not elsewhere classified
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (7)

|Aug 24, 2026
Ethical and social recognition of participation in drug clinical trials: French public views on financial compensation for participants.

|Sep 21, 2024
Safety and efficacy of apixaban versus warfarin in peritoneal dialysis patients with non-valvular atrial fibrillation: protocol for a prospective, randomised, open-label, blinded endpoint trial (APIDP2).

Maxence Ficheux, Laure Peyro-Saint-Paul, Dorothée Balayn

|Sep 13, 2024
Pharmacokinetics and safety of daptomycin administered subcutaneously in healthy volunteers: a single-blinded randomized crossover trial.

Charles Maurille, Aurélie Baldolli, Christian Creveuil

|Jun 22, 2023
Compensating patients in trials: Perspectives from an ethical committee versus sponsor.

Laure Peyro-Saint-Paul, Cathy Gaillard, Adeline Paris

|Nov 02, 2022
Bioavailability of dissolved and crushed single tablets of bictegravir, emtricitabine, tenofovir alafenamide in healthy adults: the SOLUBIC randomized crossover study.

Laurent Hocqueloux, Sandrine Lefeuvre, Julie Bois

|Oct 13, 2020
Adverse Drug Reaction Reporting Using a Mobile Device Application by Persons with Multiple Sclerosis: A Cluster Randomized Controlled Trial.

Gilles Defer, Sophie Fedrizzi, Damien Chevanne

Pageof 2

Frequent Collaborators

2 joint publications

Jean-Jacques Parienti

1 joint publications

Laurent Hocqueloux

1 joint publications

Clémence Bechade

1 joint publications

Thierry Lobbedez